SLC7A11 and glioblastoma: In this scenario, where GBM cells show great resistance to inhibition of system xc−, it is possible to speculate that they obtain cysteine ​​intracellularly from another source that implies mechanisms independent of the function of SLC7A11, which would explain the resistance to treatment with erastin or SAS.